Cai Lay Veterinary Pharmaceutical JSC (HNX:MKV)

Vietnam · Delayed Price · Currency is VND

12,800

0.00 (0.00%)

At close: Aug 12, 2026

HNX:MKV Financials Overview

Financials in millions VND. Fiscal year is January - December.

Millions VND. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2019
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '19 Dec 31, 2019
Revenue	153,971	149,787	107,036	110,906	119,634	102,410
Revenue Growth	25.44%	39.94%	-3.49%	-7.30%	16.82%	-23.90%
Gross Profit	53,384	52,679	35,937	32,232	33,029	22,298
Operating Income	21,001	24,545	12,060	10,693	11,942	8,113
Net Income	14,881	16,890	7,324	6,201	5,904	1,767
Earnings Per Share	2978.26	3378.00	1464.86	1240.00	1181.00	-
EPS Growth	137.53%	130.60%	18.13%	5.00%	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2019
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '19 Dec 31, 2019
Cash & Investments	40,592	32,417	21,175	15,192	10,177	1,794
Total Debt	-	-	-	-	18,405	41,797
Net Cash (Debt)	40,592	32,417	21,175	15,192	-8,227	-40,003
Net Cash Growth	107.32%	53.09%	39.38%	-	-	-
Net Cash Per Share	8124.06	6483.48	4235.00	3038.35	-1645.72	-

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2019
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '19 Dec 31, 2019
Operating Cash Flow	31,496	21,266	5,597	25,391	7,592	21,909
Capital Expenditures	-2,703	-1,692	-	-984.46	-561.05	-
Free Cash Flow	28,793	19,573	5,597	24,406	7,031	21,909
Free Cash Flow Growth	538.36%	249.72%	-77.07%	247.11%	-67.91%	193.49%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2019
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '19 Dec 31, 2019
Gross Margin	34.67%	35.17%	33.57%	29.06%	27.61%	21.77%
Operating Margin	13.64%	16.39%	11.27%	9.64%	9.98%	7.92%
Pretax Margin	12.09%	14.10%	8.59%	6.99%	6.27%	2.44%
Profit Margin	9.66%	11.28%	6.84%	5.59%	4.93%	1.73%
FCF Margin	18.70%	13.07%	5.23%	22.01%	5.88%	21.39%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2019
Period Ending	Aug '26 Aug 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '19 Dec 31, 2019
PE Ratio	4.30	4.47	6.69	8.71	9.32	33.95
P/FCF Ratio	2.22	3.86	8.76	2.21	7.82	2.74
PS Ratio	0.42	0.50	0.46	0.49	0.46	0.59